Mitigation Strategies To Protect Food Against Intentional Adulteration; Draft Guidance for Industry; Availability, 8599-8600 [2020-02986]
Download as PDF
Federal Register / Vol. 85, No. 31 / Friday, February 14, 2020 / Notices
Application
No.
Drug
ANDA 065484 ..
ANDA 204879 ..
Cefuroxime Sodium for Injection, EQ 7.5 g base/vial Pharmacy Bulk Package.
Cefuroxime Sodium for Injection, EQ 1.5 g base/vial ..............
Prednisolone Sodium Phosphate Oral Solution, EQ 15 mg
base/5 milliliters (mL).
Acetaminophen, Butalbital, Caffeine, and Codeine Phosphate
Capsules, 325 mg, 50 mg, 40 mg, and 30 mg.
Ampicillin and Sulbactam for Injection, EQ 1 g base/vial and
EQ 500 mg base/vial; EQ 2 g base/vial and EQ 1 g base/
vial.
Ampicillin and Sulbactam for Injection, EQ 10 g base/vial and
EQ 5 g base/vial.
Ampicillin and Sulbactam for Injection, EQ 1 g base/vial and
EQ 500 mg base/vial; EQ 2 g base/vial and EQ 1 g base/
vial.
Imipenem and Cilastatin for Injection, EQ 250 mg base/vial
and 250 mg base/vial; EQ 500 mg base/vial and 500 mg/
vial.
Meropenem for Injection, 500 mg/vial, and 1 g/vial .................
Imipenem and Cilastatin for Injection, EQ 500 mg base/vial
and 500 mg/vial.
Cefepime HCl for Injection, EQ 1 g base/vial; EQ 2 g base/
vial.
Ceftriaxone for Injection, EQ 1 g base/vial; EQ 2 g base/vial ..
Ampicillin Sodium for Injection, EQ 250 mg base/vial; EQ 500
mg base/vial; EQ 1 g base/vial; EQ 2 g base/vial.
Ampicillin Sodium for Injection, EQ 10 g base/vial Pharmacy
Bulk Package.
Cefotaxime Sodium for Injection, EQ 1 g base/vial; EQ 2 g
base/vial.
Pyridoxine HCl Injection, 100 mg/mL .......................................
ANDA 206062 ..
Doxorubicin HCl for Injection, USP, 20 mg/vial ........................
ANDA 206195 ..
Daunorubicin HCl for Injection, EQ 20 mg base/vial ................
ANDA 065503 ..
ANDA 075250 ..
ANDA 075618 ..
ANDA 090375 ..
ANDA 090646 ..
ANDA 090653 ..
ANDA 090825 ..
ANDA 090940 ..
ANDA 091007 ..
ANDA 202268 ..
ANDA 202563 ..
ANDA 202864 ..
ANDA 202865 ..
ANDA 203132 ..
khammond on DSKJM1Z7X2PROD with NOTICES
Therefore, approval of the
applications listed in the table, and all
amendments and supplements thereto,
is hereby withdrawn as of March 16,
2020. Approval of each entire
application is withdrawn, including any
strengths or products inadvertently
missing from the table. Introduction or
delivery for introduction into interstate
commerce of products without
approved new drug applications
violates section 301(a) and (d) of the
Federal Food, Drug, and Cosmetic Act
(21 U.S.C. 331(a) and (d)). Drug
products that are listed in the table that
are in inventory on March 16, 2020 may
continue to be dispensed until the
inventories have been depleted or the
drug products have reached their
expiration dates or otherwise become
violative, whichever occurs first.
Dated: February 11, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020–03025 Filed 2–13–20; 8:45 am]
BILLING CODE 4164–01–P
VerDate Sep<11>2014
16:56 Feb 13, 2020
Jkt 250001
8599
Applicant
Do.
Do.
Bausch Health US, LLC, 400 Somerset Corporate Blvd.,
Bridgewater, NJ 08807.
Hikma Pharmaceuticals USA Inc., 1809 Wilson Rd., Columbus, OH 43228.
Hospira, Inc.
Do.
Do.
Do.
Do.
Do.
Do.
Do.
Do.
Do.
Do.
Mylan Institutional, LLC, 4901 Hiawatha Dr., Rockford, IL
61103.
Hisun Pharmaceutical Hangzhou Co., LTD, 200 Crossing
Blvd., 2nd Floor, Bridgewater, NJ 08807.
Do.
Food and Drug Administration
by June 15, 2020 to ensure that the
Agency considers your comment on this
draft guidance before it begins work on
the final version of the guidance.
[Docket No. FDA–2018–D–1398]
ADDRESSES:
Mitigation Strategies To Protect Food
Against Intentional Adulteration; Draft
Guidance for Industry; Availability
Electronic Submissions
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
The Food and Drug
Administration (FDA, we, or Agency) is
announcing the availability of a
supplemental draft guidance for
industry entitled ‘‘Mitigation Strategies
to Protect Food Against Intentional
Adulteration: Guidance for Industry.’’
This supplemental draft guidance
document, when finalized, will help
food facilities that manufacture, process,
pack, or hold food, and that are required
to register under the Federal Food, Drug,
and Cosmetic Act (FD&C Act) comply
with the requirements of our regulation
entitled ‘‘Mitigation Strategies to Protect
Food Against Intentional Adulteration.’’
DATES: Submit either electronic or
written comments on the draft guidance
SUMMARY:
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
You may submit comments
on any guidance at any time as follows:
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
E:\FR\FM\14FEN1.SGM
14FEN1
8600
Federal Register / Vol. 85, No. 31 / Friday, February 14, 2020 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2018–D–1398 for ‘‘Mitigation Strategies
to Protect Food Against Intentional
Adulteration: Guidance for Industry.’’
Received comments will be placed in
the docket and, except for those
submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
VerDate Sep<11>2014
16:56 Feb 13, 2020
Jkt 250001
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852.
You may submit comments on any
guidance at any time (see 21 CFR
10.115(g)(5)).
Submit written requests for single
copies of the guidance to the Center for
Food Safety and Applied Nutrition,
Food and Drug Administration, 5001
Campus Dr., College Park, MD 20740.
Send two self-addressed adhesive labels
to assist that office in processing your
requests. See the SUPPLEMENTARY
INFORMATION section for electronic
access to the draft guidance document.
FOR FURTHER INFORMATION CONTACT:
Ryan Newkirk, Center for Food Safety
and Applied Nutrition (HFS–005), Food
and Drug Administration, 5001 Campus
Dr., College Park, MD 20740, 240–402–
3712, ryan.newkirk@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
The FDA Food Safety Modernization
Act (FSMA) (Pub. L. 111–353) enables
FDA to better protect public health by
helping to ensure the safety and security
of the food supply. FSMA enables FDA
to focus more on preventing food safety
problems rather than relying primarily
on reacting to problems after they occur.
FSMA added to the FD&C Act several
new sections that reference intentional
adulteration. For example, section 418
of the FD&C Act (21 U.S.C. 350g)
addresses intentional adulteration in the
context of facilities that manufacture,
process, pack, or hold food, and that are
required to register under section 415
(21 U.S.C. 350d). Section 420 of the
FD&C Act (21 U.S.C. 350i) addresses
intentional adulteration in the context
of high-risk foods and exempts farms
except for farms that produce milk.
We are announcing the availability of
a supplemental draft guidance for
industry entitled ‘‘Mitigation Strategies
to Protect Food Against Intentional
Adulteration: Guidance for Industry.’’
This multi-chapter supplemental draft
guidance for industry is intended to
help food facilities required to comply
develop and implement some of the
components of a food defense plan, and
meet other requirements under 21 CFR
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
part 121. We are announcing the
availability of the following chapters
and appendices:
• Chapter 5—Mitigation Strategies
Management Components: Food
Defense Corrective Actions
• Chapter 6—Mitigation Strategies
Management Components: Food
Defense Verification
• Chapter 7—Reanalysis
• Chapter 9—Records
• Appendix 2—Mitigation Strategies in
the Food Defense Mitigation
Strategies Database
• Appendix 3—Determination of Status
as a Very Small Business or Small
Business Under Part 121: Mitigation
Strategies to Protect Food Against
Intentional Adulteration
II. Significance of Guidance
This level 1 draft guidance is being
issued consistent with FDA’s good
guidance practices regulation (21 CFR
10.115). The draft guidance, when
finalized, will represent the current
thinking of FDA on food defense
measures against intentional
adulteration for the regulation
‘‘Mitigation Strategies to Protect Food
Against Intentional Adulteration.’’ It
does not establish any rights for any
person and is not binding on FDA or the
public. You can use an alternative
approach if it satisfies the requirements
of the applicable statutes and
regulations.
III. Paperwork Reduction Act of 1995
This draft guidance refers to
previously approved collections of
information found in FDA regulations.
These collections of information are
subject to review by the Office of
Management and Budget (OMB) under
the Paperwork Reduction Act of 1995
(44 U.S.C. 3501–3520). The collections
of information in 21 CFR part 121 have
been approved under OMB control
number 0910–0812.
IV. Electronic Access
Persons with access to the internet
may obtain the draft guidance at either
https://www.fda.gov/regulatoryinformation/search-fda-guidancedocuments or https://
www.regulations.gov. Use the FDA
website listed in the previous sentence
to find the most current version of the
guidance.
Dated: February 10, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020–02986 Filed 2–13–20; 8:45 am]
BILLING CODE 4164–01–P
E:\FR\FM\14FEN1.SGM
14FEN1
Agencies
[Federal Register Volume 85, Number 31 (Friday, February 14, 2020)]
[Notices]
[Pages 8599-8600]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-02986]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2018-D-1398]
Mitigation Strategies To Protect Food Against Intentional
Adulteration; Draft Guidance for Industry; Availability
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of availability.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA, we, or Agency) is
announcing the availability of a supplemental draft guidance for
industry entitled ``Mitigation Strategies to Protect Food Against
Intentional Adulteration: Guidance for Industry.'' This supplemental
draft guidance document, when finalized, will help food facilities that
manufacture, process, pack, or hold food, and that are required to
register under the Federal Food, Drug, and Cosmetic Act (FD&C Act)
comply with the requirements of our regulation entitled ``Mitigation
Strategies to Protect Food Against Intentional Adulteration.''
DATES: Submit either electronic or written comments on the draft
guidance by June 15, 2020 to ensure that the Agency considers your
comment on this draft guidance before it begins work on the final
version of the guidance.
ADDRESSES: You may submit comments on any guidance at any time as
follows:
Electronic Submissions
Submit electronic comments in the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
[[Page 8600]]
If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').
Written/Paper Submissions
Submit written/paper submissions as follows:
Mail/Hand Delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
Instructions: All submissions received must include the Docket No.
FDA-2018-D-1398 for ``Mitigation Strategies to Protect Food Against
Intentional Adulteration: Guidance for Industry.'' Received comments
will be placed in the docket and, except for those submitted as
``Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m.
and 4 p.m., Monday through Friday.
Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly available, you
can provide this information on the cover sheet and not in the body of
your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852.
You may submit comments on any guidance at any time (see 21 CFR
10.115(g)(5)).
Submit written requests for single copies of the guidance to the
Center for Food Safety and Applied Nutrition, Food and Drug
Administration, 5001 Campus Dr., College Park, MD 20740. Send two self-
addressed adhesive labels to assist that office in processing your
requests. See the SUPPLEMENTARY INFORMATION section for electronic
access to the draft guidance document.
FOR FURTHER INFORMATION CONTACT: Ryan Newkirk, Center for Food Safety
and Applied Nutrition (HFS-005), Food and Drug Administration, 5001
Campus Dr., College Park, MD 20740, 240-402-3712,
[email protected].
SUPPLEMENTARY INFORMATION:
I. Background
The FDA Food Safety Modernization Act (FSMA) (Pub. L. 111-353)
enables FDA to better protect public health by helping to ensure the
safety and security of the food supply. FSMA enables FDA to focus more
on preventing food safety problems rather than relying primarily on
reacting to problems after they occur.
FSMA added to the FD&C Act several new sections that reference
intentional adulteration. For example, section 418 of the FD&C Act (21
U.S.C. 350g) addresses intentional adulteration in the context of
facilities that manufacture, process, pack, or hold food, and that are
required to register under section 415 (21 U.S.C. 350d). Section 420 of
the FD&C Act (21 U.S.C. 350i) addresses intentional adulteration in the
context of high-risk foods and exempts farms except for farms that
produce milk.
We are announcing the availability of a supplemental draft guidance
for industry entitled ``Mitigation Strategies to Protect Food Against
Intentional Adulteration: Guidance for Industry.'' This multi-chapter
supplemental draft guidance for industry is intended to help food
facilities required to comply develop and implement some of the
components of a food defense plan, and meet other requirements under 21
CFR part 121. We are announcing the availability of the following
chapters and appendices:
Chapter 5--Mitigation Strategies Management Components: Food
Defense Corrective Actions
Chapter 6--Mitigation Strategies Management Components: Food
Defense Verification
Chapter 7--Reanalysis
Chapter 9--Records
Appendix 2--Mitigation Strategies in the Food Defense
Mitigation Strategies Database
Appendix 3--Determination of Status as a Very Small Business
or Small Business Under Part 121: Mitigation Strategies to Protect Food
Against Intentional Adulteration
II. Significance of Guidance
This level 1 draft guidance is being issued consistent with FDA's
good guidance practices regulation (21 CFR 10.115). The draft guidance,
when finalized, will represent the current thinking of FDA on food
defense measures against intentional adulteration for the regulation
``Mitigation Strategies to Protect Food Against Intentional
Adulteration.'' It does not establish any rights for any person and is
not binding on FDA or the public. You can use an alternative approach
if it satisfies the requirements of the applicable statutes and
regulations.
III. Paperwork Reduction Act of 1995
This draft guidance refers to previously approved collections of
information found in FDA regulations. These collections of information
are subject to review by the Office of Management and Budget (OMB)
under the Paperwork Reduction Act of 1995 (44 U.S.C. 3501-3520). The
collections of information in 21 CFR part 121 have been approved under
OMB control number 0910-0812.
IV. Electronic Access
Persons with access to the internet may obtain the draft guidance
at either https://www.fda.gov/regulatory-information/search-fda-guidance-documents or https://www.regulations.gov. Use the FDA website
listed in the previous sentence to find the most current version of the
guidance.
Dated: February 10, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020-02986 Filed 2-13-20; 8:45 am]
BILLING CODE 4164-01-P